Baroreflex sensitivity in patients with resistant hypertension: Spironolactone effects

      Objective: To assess the relationship between pressor response to adding of spironolactone to antihypertensive treatment and spontaneous baroreflex sensitivity (BRS) in patients with resistant hypertension (RHTN) and its associations with lowering of blood pressure (BP).
      To read this article in full you will need to make a payment


      Subscribe to Autonomic Neuroscience: Basic and Clinical
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect